Did a drug prevent this man's ALS?

Family genetics indicated his fate, but an experimental therapy may change his course.

August 2, 2025 Check out STAT+

Sponsored By

Don't miss our next STAT event this Monday: Women's Health, Unstuck. Join Bill Gates and other experts for a discussion on flattening barriers to improving women's health. In-person tickets are sold out, but register now for livestream access.

Courtesy Jeff Vierstra STAT+ | Did a drug prevent this man's ALS? Jeff Vierstra was likely doomed by his DNA. A radical experiment gave him a chance to rewrite his fate — before ALS symptoms ever began. By Jason Mast Marian F. Moratinos for STAT STAT+ | Jay Bhattacharya once studied health disparities. As NIH director, he's allowed such research to wither STAT examines NIH director's journey from studying health disparities to heading agency where 1,000 grants have been axed over DEI concerns By Anil Oza, Usha Lee McFarling, and Eric Boodman Photo illustration Alex Hogan/STAT STAT+ | Inside the fall of Vinay Prasad at the FDA Prasad's departure follows criticism from MAGA and MAHA, a campaign by a right-wing activist, and a controversy over a rare disease drug. By Lizzy Lawrence STAT+ | Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray Gerald Parker's exit leaves White House's pandemic preparedness team leaderless. Expert warnings of danger called "fake news" by Trump administration. By Katherine Eban STAT+ | Kevin Hall, uncensored: Top nutrition scientist on clashing with MAHA and what he actually eats Kevin Hall says NIH tried to silence his nutrition research. With his lab closed, he's revealing how ultra-processed foods impact public health. By Sarah Todd Budget cuts knock down a 'pillar of public health,' ending nutrition education Despite its documented success, SNAP-Ed, the long-running educational effort to help Americans with low incomes eat healthy, is ending. By Elizabeth Cooney Opinion: What I learned by going off SSRIs after nearly a decade STAT's Sarah Todd happened to go off escitalopram amid new public scrutiny of antidepressants. Here's what she found. By Sarah Todd STAT+ | Cellular 'trash bins' might be a key to reviving multi-cancer early detection tests Scientists are shifting from DNA-based blood tests to tiny vesicles once dismissed as cellular trash. They may help catch cancer sooner By Angus Chen and Marissa Russo

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser